Real-World Effectiveness and Safety Outcomes of Acalabrutinib Treatment By Line of Therapy in Patients with Chronic Lymphocytic Leukemia and/or Small Lymphocytic Lymphoma

被引:0
|
作者
Jacobs, Ryan W. [1 ]
Teschemaker, Anna [2 ]
Hakre, Shweta [2 ]
Tian, Hongping [3 ]
Pyrih, Nick [3 ]
Wahlstrom, Svea K. [4 ]
Cui, Lianzhou [3 ]
机构
[1] Atrium Hlth Levine Canc Inst, Charlotte, NC USA
[2] AstraZeneca, Gaithersburg, MD USA
[3] Cobbs Creek Hlth Care, Newtown Sq, PA USA
[4] AstraZeneca, Wilmington, DE USA
关键词
D O I
10.1182/blood-2023-174974
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Real-world treatment patterns and characteristics in patients with chronic lymphocytic leukemia
    Schenkel, Brad
    Rider, Alex
    Macomson, Brian
    Hallworth, Pam
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (08)
  • [32] Real-world risk of bleeding events in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) treated with BTKi
    Moslehi, Javid J.
    Wahlstrom, Svea K.
    Teschemaker, Anna
    Mackey, Rachel H.
    DeVincenzo, Diana
    Carabuena, Leslie A.
    Thompson, Samantha L.
    Gordon, Brittaney
    Rosenthal, Ning A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [33] Real-World Effectiveness and Safety Outcomes of Acalabrutinib Treatment in Patients with Relapsed/Refractory Mantle Cell Lymphoma
    Patel, Krish
    Teschemaker, Anna
    Tian, Hongping
    Pyrih, Nick
    Kolvenbag, Geert
    Patel, Shweta
    Wahlstrom, Svea K.
    Cui, Lianzhou
    BLOOD, 2024, 144 : 7745 - 7745
  • [34] Real-world treatment outcomes in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who were treated with first-line single-agent ibrutinib vs. chemoimmunotherapy
    Wang, Ruibin
    Ding, Zhijie
    Lu, Xiaoxiao
    Mavani, Heena
    He, Jinghua
    Qureshi, Zaina P.
    Pinilla-Ibarz, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [35] BTK Inhibitors Versus Venetoclax as First- or Second-Line Therapy in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Real-World Evidence Study
    Roeker, Lindsey E.
    Han, Yi
    Teschemaker, Anna
    Mato, Anthony R.
    Thompson, Meghan C.
    AMERICAN JOURNAL OF HEMATOLOGY, 2025, 100 (04) : 720 - 723
  • [36] Real-world patterns and sequences of targeted therapy use in chronic lymphocytic leukemia and small lymphocytic lymphoma in the United States: a longitudinal study
    Huntington, Scott F.
    Cheng, Wendy Y.
    Sarpong, Eric M.
    Leng, Siyang
    Farooqui, Mohammed Z. H.
    Agu, Uchechukwu Samuel
    Catillon, Maryaline
    Lejeune, Dominique
    Downes, Nathaniel
    Matay, Lisa
    Duh, Mei Sheng
    De Nigris, Enrico
    LEUKEMIA & LYMPHOMA, 2024, 65 (07) : 932 - 942
  • [37] Real-world patterns and sequences of targeted therapy use in chronic lymphocytic leukemia and small lymphocytic lymphoma in the United States: a longitudinal study
    Huntington, Scott F.
    Cheng, Wendy Y.
    Sarpong, Eric M.
    Leng, Siyang
    Farooqui, Mohammed Z. H.
    Agu, Uchechukwu Samuel
    Catillon, Maryaline
    Lejeune, Dominique
    Downes, Nathaniel
    Matay, Lisa
    Duh, Mei Sheng
    De Nigris, Enrico
    LEUKEMIA & LYMPHOMA, 2024, : 932 - 942
  • [38] Real-World Outcomes Among 2L+Patients with Chronic Lymphocytic Leukemia (CLL) By Line of Therapy (LOT)
    Davids, Matthew S.
    Ambrose, Jacob
    De Nigris, Enrico
    Prescott, Jennifer
    Leng, Siyang
    Farooqui, Mohammed Z. H.
    Gandra, Shravanthi R.
    Zettler, Christina M.
    Fernandes, Laura L.
    Wang, Ching-Kun
    Shadman, Mazyar
    BLOOD, 2023, 142
  • [39] Real-world outcomes for 205 patients with chronic lymphocytic leukemia treated with ibrutinib
    Aarup, Kathrine
    Rotbain, Emelie Curovic
    Enggaard, Lisbeth
    Pedersen, Robert Schou
    Bergmann, Olav Jonas
    Thomsen, Rasmus Heje
    Frederiksen, Mikael
    Frederiksen, Henrik
    Nielsen, Tine
    Christiansen, Ilse
    Andersen, Michael Asger
    Niemann, Carsten Utoft
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 105 (05) : 646 - 654
  • [40] Racial disparities in chronic lymphocytic leukemia/small lymphocytic lymphoma accounting for small molecule inhibitors: A real-world cohort analysis
    Kittai, Adam S.
    Hang, Ying
    Bhat, Seema A.
    Clark, Abi
    Grever, Michael
    Rhodes, Joanna M.
    Roberts, Melyssa
    Rogers, Kerry A.
    Teschemaker, Anna
    Munoz-Sagastibelza, Maria
    Woyach, Jennifer A.
    Barrientos, Jacqueline C.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (04) : 780 - 784